m7G(5')ppp(5')A RNA Cap Structure Analog
Product informationCode | Name | Size | Quantity | Price | |
---|---|---|---|---|---|
S1405S |
m7G(5')ppp(5')A RNA Cap Structure Analog |
1 µmol | - | Unavailable in your region | |
S1405L |
m7G(5')ppp(5')A RNA Cap Structure Analog |
5 µmol | - | Unavailable in your region |
m7G(5')ppp(5')A RNA Cap Structure Analog
Product Introduction
Co-transcriptional capping with T7 RNA polymerase from the phi2.5 promoter that contains an A at the transcription initiation site.
- Synthesis of m7G capped RNA for in vitro splicing assays.
- Synthesis of m7G capped RNA for transfection or microinjection.
Catalog # | Size | Concentration |
---|---|---|
S1405S | 1.0 µmol | |
S1405L | 5.0 µmol |
Featured Videos
View Video Library-
Avoiding RNase Contamination
- Product Information
- Protocols, Manuals & Usage
- Tools & Resources
- Citations & Technical Literature
- Quality, Safety & Legal
- Other Products You May Be Interested In
Product Information
Description
Description: The 5´terminal m7G cap present on most eukaryotic mRNAs promotes translation in vitro at the initiation level (1,2,3). For most RNAs, elimination of the cap structure causes a loss of stability, especially against exonuclease degradation (4), and a decrease in the formation of the initiation complex of mRNAs for protein synthesis (4,5). Certain prokaryotic mRNAs containing a 5´ terminal cap structure are translated as efficiently as or more efficiently than eukaryotic mRNAs in a eukaryotic cell-free protein synthesizing system (5). Also a cap requirement has been observed for splicing eukaryotic substrate RNAs (6).A method using E. coli RNA Polymerase primed with m7G(5´)ppp(5´)G or m7G(5´)ppp(5´)A for an efficient in vitro synthesis of capped RNAs has been developed by Contreas (7). Larger amounts of capped RNAs are produced by transcription systems using SP6 RNA polymerase primed with m7G(5´)ppp(5´)G (6).
Sequence
7mG(5')ppp(5')A- This product is related to the following categories:
Reagents Supplied
Reagents Supplied
The following reagents are supplied with this product:
NEB # | Component Name | Component # | Stored at (°C) | Amount | Concentration | |
---|---|---|---|---|---|---|
Properties & Usage
Supplied As
Dried Sodium SaltSuggested Working Concentration
10mMRecommended Resuspension Volume
100 μlProduct Notes
- Addition of 100 µl of water gives approximately a 10 mM solution.
References
- Shatkin, A.J. (1978). Cell. 9, 645-653.
- Fillipowicz, W. (1978). FEBS Lett.. 96, 1-11.
- Banerjee, A.K. (1980). Microbiol. Rev.. 44, 175-205.
- Miura, K. (1981). Adv. Biophys.. 14, 205-238.
- Shatkin, A.J. et al. (1977). Nucl. Acids Res.. 4, 3065-3081.
- Konarska, M.M. et al. (1984). Cell. 38, 731-736.
- Contreas, R. et al. (1982). Nucl. Acids Res.. 10, 6353-6363.
- Paterson, B.M. and Rosenberg, M. (1979). Nature. 279, 696-701.
Protocols, Manuals & Usage
Protocols
Tools & Resources
Selection Charts
Citations & Technical Literature
Citations
Additional Citations
Quality, Safety & Legal
Quality Assurance Statement
Quality Control tests are performed on each new lot of NEB product to meet the specifications designated for it. Specifications and individual lot data from the tests that are performed for this particular product can be found and downloaded on the Product Specification Sheet, Certificate of Analysis, data card or product manual. Further information regarding NEB product quality can be found here.Specifications
The Specification sheet is a document that includes the storage temperature, shelf life and the specifications designated for the product. The following file naming structure is used to name these document files: [Product Number]_[Size]_[Version]Certificate Of Analysis
The Certificate of Analysis (COA) is a signed document that includes the storage temperature, expiration date and quality controls for an individual lot. The following file naming structure is used to name these document files: [Product Number]_[Size]_[Version]_[Lot Number]- S1405S_v1_10015676
- S1405L_v1_10015677
- S1405L_v1_10048242
- S1405L_v1_10051797
- S1405L_v1_10055291
- S1405S_v1_10048243
- S1405S_v1_10058021
- S1405S_v1_10064796
- S1405L_v1_10058020
- S1405L_v1_10077409
- S1405S_v1_10081858
- S1405S_v1_10088303
- S1405L_v1_10088302
- S1405L_v1_10106604
- S1405S_v1_10113843
- S1405S_v1_10116061
- S1405L_v1_10113844
- S1405S_v1_10123099
- S1405S_v2_10134523
- S1405L_v2_10150798
- S1405L_v2_10163667
- S1405S_v2_10163666
- S1405L_v2_10168730
- S1405L_v2_10200516
- S1405S_v2_10195961
- S1405L_v2_10222690
- S1405L_v2_10262787
Safety DataSheets
The following is a list of Safety Data Sheet (SDS) that apply to this product to help you use it safely.m7G(5')ppp(5')A RNA Cap Structure Analog
Legal and Disclaimers
Products and content are covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB). The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; it indicates where the content was originally developed. The use of this product may require the buyer to obtain additional third-party intellectual property rights for certain applications. For more information, please email busdev@neb.com.This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
New England Biolabs (NEB) is committed to practicing ethical science – we believe it is our job as researchers to ask the important questions that when answered will help preserve our quality of life and the world that we live in. However, this research should always be done in safe and ethical manner. Learn more.
Other Products You May Be Interested In
The supporting documents available for this product can be downloaded below.
Protocol
Capped RNA Synthesis (E2050)
Protocol
Capped RNA Synthesis (E2050)
Protocol
Capped RNA Synthesis (E2050)
Protocol
Capped RNA Synthesis (E2050)